Traditional pharmaceuticals regulate specific metabolic reactions, but have been limited in effectiveness for certain diseases by the availability of adequate endogenous substrates.
In contrast, our treatments not only modulate factors controlling key metabolic reactions, but also provide the necessary substrates for the reactions that are activated. The result is that the targeted reactions can proceed at the optimal rate.
This approach yields unparalleled results when targeting specific diseases and health conditions that traditional pharmaceuticals have been unsucessful in treating.